Literature DB >> 9002393

Clinical features of schizophrenia in a woman with hyperandrogenism.

L C Kopala1, R Lewine, K P Good, M Fluker, J S Martzke, J S Lapointe, W G Honer.   

Abstract

Ample evidence supports sex differences in the clinical features of schizophrenia. In this regard, estrogen may contribute to later onset and less severe course of illness in women. Direct investigation of hormonal status in schizophrenia is extremely difficult. The present report documents the clinical features of schizophrenia in a young woman with long-standing hyperandrogenism related to polycystic ovarian disease. We postulate that hyperandrogenism contributed to a relatively early onset, olfactory dysfunction, and other clinical features of schizophrenia more commonly associated with men. Additionally, acute estrogen depletion following cessation of oral contraceptives may have precipitated psychosis, while recommencement of oral contraceptives could have contributed to subsequent improvement in symptoms.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9002393      PMCID: PMC1188817     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  25 in total

1.  Menstruation and acute psychiatric illnesses.

Authors:  K DALTON
Journal:  Br Med J       Date:  1959-01-17

2.  Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone.

Authors:  L C Kopala; D Fredrikson; K P Good; W G Honer
Journal:  Biol Psychiatry       Date:  1996-02-15       Impact factor: 13.382

3.  The role of estrogen in schizophrenia.

Authors:  M V Seeman
Journal:  J Psychiatry Neurosci       Date:  1996-03       Impact factor: 6.186

4.  Sex differences in olfactory function in schizophrenia.

Authors:  L Kopala; C Clark; T A Hurwitz
Journal:  Am J Psychiatry       Date:  1989-10       Impact factor: 18.112

5.  Variation in symptom severity over the menstrual cycle of schizophrenics.

Authors:  J D Hallonquist; M V Seeman; M Lang; N A Rector
Journal:  Biol Psychiatry       Date:  1993-02-01       Impact factor: 13.382

6.  Olfactory deficits in neuroleptic naive patients with schizophrenia.

Authors:  L C Kopala; C Clark; T Hurwitz
Journal:  Schizophr Res       Date:  1993-01       Impact factor: 4.939

7.  Structural brain abnormalities in the major psychoses: a quantitative review of the evidence from computerized imaging.

Authors:  S Raz; N Raz
Journal:  Psychol Bull       Date:  1990-07       Impact factor: 17.737

8.  Olfactory identification ability in pre- and postmenopausal women with schizophrenia.

Authors:  L C Kopala; K Good; W G Honer
Journal:  Biol Psychiatry       Date:  1995-07-01       Impact factor: 13.382

Review 9.  Modulation of brain dopamine transmission by sex steroids.

Authors:  T Di Paolo
Journal:  Rev Neurosci       Date:  1994 Jan-Mar       Impact factor: 4.353

Review 10.  Gender differences in schizophrenia: hormonal effect or subtypes?

Authors:  D J Castle; K Abel; N Takei; R M Murray
Journal:  Schizophr Bull       Date:  1995       Impact factor: 9.306

View more
  3 in total

Review 1.  Scent of a disorder: olfactory functioning in schizophrenia.

Authors:  Paul J Moberg; Bruce I Turetsky
Journal:  Curr Psychiatry Rep       Date:  2003-08       Impact factor: 5.285

2.  Diagnosing cycloid psychosis.

Authors:  L C Kopala
Journal:  J Psychiatry Neurosci       Date:  1998-09       Impact factor: 6.186

3.  Is oestrogen a 'biological neuroleptic'?

Authors:  Subhagata Chattopadyay
Journal:  Indian J Psychiatry       Date:  2003-10       Impact factor: 1.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.